X-8170149-G-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_016378.3(VCX2):​c.303C>G​(p.His101Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0 ( 0 hom., 0 hem., cov: 8)
Exomes 𝑓: 0.000022 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

VCX2
NM_016378.3 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.55
Variant links:
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05393651).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCX2NM_016378.3 linkc.303C>G p.His101Gln missense_variant Exon 3 of 3 ENST00000317103.5 NP_057462.2 Q9H322

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCX2ENST00000317103.5 linkc.303C>G p.His101Gln missense_variant Exon 3 of 3 1 NM_016378.3 ENSP00000321309.4 Q9H322
ENSG00000285679ENST00000649338.1 linkn.263-58186G>C intron_variant Intron 3 of 4
ENSG00000285679ENST00000659022.1 linkn.972-58186G>C intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
56115
Hom.:
0
Cov.:
8
AF XY:
0.00
AC XY:
0
AN XY:
6541
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000111
AC:
1
AN:
89764
Hom.:
0
AF XY:
0.0000364
AC XY:
1
AN XY:
27444
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000254
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000220
AC:
23
AN:
1043248
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
329404
show subpopulations
Gnomad4 AFR exome
AF:
0.0000399
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000102
Gnomad4 SAS exome
AF:
0.0000197
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000212
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
56108
Hom.:
0
Cov.:
8
AF XY:
0.00
AC XY:
0
AN XY:
6550
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ESP6500AA
AF:
0.00319
AC:
12
ESP6500EA
AF:
0.00151
AC:
10
ExAC
AF:
0.000124
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 24, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.303C>G (p.H101Q) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a C to G substitution at nucleotide position 303, causing the histidine (H) at amino acid position 101 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.29
DANN
Benign
0.42
DEOGEN2
Benign
0.0026
T
FATHMM_MKL
Benign
0.0011
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.0011
T
MetaRNN
Benign
0.054
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.2
N
REVEL
Benign
0.13
Sift
Benign
0.28
T
Sift4G
Benign
0.23
T
Polyphen
0.79
P
Vest4
0.10
MutPred
0.052
Gain of solvent accessibility (P = 0.0155);
MVP
0.048
MPC
0.0091
ClinPred
0.11
T
GERP RS
0.046
Varity_R
0.18
gMVP
0.0018

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145994467; hg19: chrX-8138190; API